Portfolio
Strategy
Team
News
Careers
Contact
Investor Login
Portfolio
Strategy
Team
News
Careers
Contact
Artiva Biotherapeutics Readies for the Next Phase of Growth with the Appointment of Neha Krishnamohan as CFO and EVP, Corporate Development and Promotion of Jennifer Bush to Chief Operating Officer
Read Article
News
2024
2023
Archive
Search news articles
June 1, 2009
ENTREMED PRESENTS RESULTS OF ENMD-2076 PHASE 1 STUDY IN ADVANCED CANCER PATIENTS
May 16, 2009
ACHAOGEN DATA SHOW RAPID RISE IN RATES OF RESISTANCE TO CURRENT ANTIBIOTICS; ILLUSTRATE GLOBAL NEED FOR NEW, WELL-TOLERATED AGENTS TO ADDRESS VARIED MECHANISMS OF RESISTANCE
May 13, 2009
SYNOSIA THERAPEUTICS BEGINS PHASE I TRIAL OF A NEW GENERATION TREATMENT FOR COGNITIVE IMPAIRMENT
May 1, 2009
PULMATRIX ANNOUNCES PH 1B/2A CLINICAL TRIAL OF NOVEL ICALM THERAPY FOR FLU
March 10, 2009
SYNOSIA ANNOUNCES SECOND AGREEMENT WITH ROCHE
March 9, 2009
IGENICA APPOINTS DR. MIKE ROTHE AS CEO AFTER CLOSING SERIES A FINANCING
March 3, 2009
ACHAOGEN SIGNS $26.6 MILLION CONTRACT WITH NIAID FOR DEVELOPMENT OF NEW THERAPY TO TREAT RESISTANT STRAINS OF NIAID CATEGORY A AND B PRIORITY PATHOGENS
February 24, 2009
PEARL THERAPEUTICS SECURES $8 MILLION IN DEBT FINANCING
February 9, 2009
ENTREMED PRESENTS INITIAL CLINICAL RESULTS FOR ENMD-2076
February 9, 2009
BIOTECHS BEFRIEND NON-DILUTIVE FUNDS
« Previous Page
1
…
116
117
118
119
Next Page »